US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 0.8243
  • -0.0394-4.56%
Trading Mar 24 12:03 ET
153.41MMarket Cap-1.42P/E (TTM)

Nektar Therapeutics Key Stats

Nektar Therapeutics Q4 2024 Earnings Date

Currency:USDMar 12, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
36.66M
29.18M
-7.48M
Miss Est.
+53.48%
+22.15%
-20.41%
EPS
-0.14
0.03
+0.17
Beat Est.
+38.56%
+113.64%
+122.21%
Buy

Mar 15, 2025

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 15.704M--
--2025/Q1-- / 15.606M--
Mar 12, 20252024/Q429.175M / 36.658M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 15.704M--
--2025/Q1-- / 15.606M--
Mar 12, 20252024/Q429.175M / 36.658M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 15, 2025

Buy

  • Buy

    62.50%
  • Hold

    25.00%
  • Sell

    12.50%

Price Target

No Data